(Q51890683)

17 April 2018

title

The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy. (English)

1 reference

17 April 2018

1 reference

1 reference

1 reference

1 reference

Xia Wu

1

1 reference

17 April 2018

Qin-Mei Feng

2

1 reference

17 April 2018

Ying Wang

3

1 reference

17 April 2018

Jun Shi

4

1 reference

17 April 2018

Hai-Liang Ge

5

1 reference

17 April 2018

Wen Di

6

1 reference

17 April 2018

publication date

30 August 2009

1 reference

17 April 2018

Cancer Immunology, Immunotherapy

published in

1 reference

17 April 2018

volume

59

1 reference

17 April 2018

issue

2

1 reference

17 April 2018

page(s)

279-291

1 reference

17 April 2018

https://scigraph.springernature.com/pub.10.1007/s00262-009-0749-9

exact match

0 references

cites work

Tumor-specific Tc1, but not Tc2, cells deliver protective antitumor immunity.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-009-0749-9

Immune-potentiating effects of the chemotherapeutic drug cyclophosphamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-009-0749-9

Induction of tumor cell apoptosis in vivo increases tumor antigen cross-presentation, cross-priming rather than cross-tolerizing host tumor-specific CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-009-0749-9

Predominant Th2/Tc2 Polarity of Tumor-Infiltrating Lymphocytes in Human Cervical Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00262-009-0749-9

10.1007/S00262-009-0749-9

21 January 2018

Identifiers

DOI

1 reference

17 April 2018

PubMed ID

19727719

1 reference

17 April 2018